Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AMLZhihong Zeng, Marina Konopleva|Blood|2008Cited by 512
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemiasZhihong Zeng, Marina Konopleva, Ismael Samudio et al.|Molecular Cancer Therapeutics|2006Cited by 186
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Marina Konopleva|Blood|2012Cited by 124
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i> -Mutated Myeloid MalignanciesCurtis A. Lachowiez, Courtney D. DiNardo, Yi June Kim et al.|Blood Cancer Discovery|2023Cited by 122